PDGF and FGF2 regulate oligodendrocyte progenitor responses to demyelination

被引:94
|
作者
Frost, EE
Nielsen, JA
Le, TQ
Armstrong, RC [1 ]
机构
[1] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA
[2] Uniformed Serv Univ Hlth Sci, Program Mol & Cell Biol, Bethesda, MD 20814 USA
来源
JOURNAL OF NEUROBIOLOGY | 2003年 / 54卷 / 03期
关键词
PDGF; FGF2; remyelination; oligodendrocyte progenitor; demyelinating disease;
D O I
10.1002/neu.10158
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Acute demyelination of adult CNS, resulting from trauma or disease, is initially followed by remyelination. However, chronic lesions with subsequent functional impairment result from eventual failure of the remyelination process, as seen in multiple sclerosis. Studies using animal models of successful remyelination delineate a progression of events facilitating remyelination. A universal feature of this repair process is extensive proliferation of oligodendrocyte progenitor cells (OPs) in response to demyelination. To investigate signals that regulate OP proliferation in response to demyelination we used murine hepatitis virus-A59 (MHV-A59) infection of adult mice to induce focal demyelination throughout the spinal cord followed by spontaneous remyelination. We cultured glial cells directly from demyelinating and remyelinating spinal cords using conditions that maintain the dramatically enhanced OP proliferative response prior to CNS remyelination. We identify PDGF and FGF2 as significant mitogens regulating this proliferative response. Furthermore, we demonstrate endogenous PDGF and FGF2 activity in these glial cultures isolated from demyelinated CNS tissue. These findings correlate well with our previous demonstration of increased in vivo expression of PDGF and FGF2 ligand and corresponding receptors in MHV-A59 lesions. Together these studies support the potential of these pathways to function in vivo as critical factors in regulating remyelination. (C) 2003 Wiley Periodicals, Inc.
引用
收藏
页码:457 / 472
页数:16
相关论文
共 50 条
  • [21] Inducible expression of FGF2 by a rat oligodendrocyte precursor cell line promotes CNS myelination in vitro
    Magy, L
    Mertens, C
    Avellana-Adalid, V
    Keita, M
    Lachapelle, F
    Nait-Oumesmar, B
    Fontaine, B
    Baron-Van Evercooren, A
    EXPERIMENTAL NEUROLOGY, 2003, 184 (02) : 912 - 922
  • [22] EXTRINSIC AND INTRINSIC MECHANISMS TO REGULATE OLIGODENDROCYTE PROGENITOR DEVELOPMENT
    Colognato, H.
    JOURNAL OF NEUROCHEMISTRY, 2009, 108 : 21 - 21
  • [23] Repopulation of oligodendrocyte progenitor cell depleted tissue in a model of chronic demyelination
    Foote, AK
    Blakemore, WF
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2005, 31 (02) : 105 - 114
  • [24] Demyelination-induced changes in oligodendrocyte progenitor cells in the adult CNS
    Lubetzki, C.
    Moyon, S.
    Tepavcevic, V.
    Aigrot, M. -S.
    Dubessy, A. L.
    GLIA, 2015, 63 : E26 - E27
  • [25] Genetic fate mapping of oligodendrocyte progenitor cells in a mouse demyelination model
    Islam, Mohammad Shyful
    Tatsumi, Kouko
    Okuda, Hiroaki
    Shiosaka, Sadao
    Wanaka, Akio
    NEUROSCIENCE RESEARCH, 2008, 61 : S227 - S227
  • [26] The integrin-binding defective FGF2 mutants potently suppress FGF2 signalling and angiogenesis
    Mori, Seiji
    Hatori, Nobuaki
    Kawaguchi, Naomasa
    Hamada, Yoshinosuke
    Shih, Tsung-Chieh
    Wu, Chun-Yi
    Lam, Kit S.
    Matsuura, Nariaki
    Yamamoto, Hirofumi
    Takada, Yoko K.
    Takada, Yoshikazu
    BIOSCIENCE REPORTS, 2017, 37
  • [27] The human FGF2 level as an important cardiovascular risk factor is strongly influenced by the FGF2 genotype
    Schulz, S
    Greiser, P
    Schagdarsurengin, U
    Suess, T
    Mueller-Werdan, U
    Werdan, K
    Glaeser, C
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 329 - 329
  • [28] Serial measurements of serum PDGF-AA, PDGF-BB, FGF2, and VEGF in multiresistant ovarian cancer patients treated with bevacizumab
    Madsen, Christine Vestergaard
    Steffensen, Karina Dahl
    Olsen, Dorte Aalund
    Waldstrom, Marianne
    Smerdel, Maja
    Adimi, Parvin
    Brandslund, Ivan
    Jakobsen, Anders
    JOURNAL OF OVARIAN RESEARCH, 2012, 5
  • [29] FGF2 Promotes Resistance To Quizartinib In Vitro, and FGF2 Increases In The Marrow Of Patients Prior To Resistance
    Traer, Elie
    Javidi-Sharifi, Nathalie
    Agarwal, Anupriya
    Dunlap, Jennifer B.
    English, Isabel
    Martinez, Jacqueline
    Kovacsovics, Tibor J.
    Tyner, Jeffrey W.
    Wong, Melissa
    Druker, Brian J.
    BLOOD, 2013, 122 (21)
  • [30] Serial measurements of serum PDGF-AA, PDGF-BB, FGF2, and VEGF in multiresistant ovarian cancer patients treated with bevacizumab
    Christine Vestergaard Madsen
    Karina Dahl Steffensen
    Dorte Aalund Olsen
    Marianne Waldstrøm
    Maja Smerdel
    Parvin Adimi
    Ivan Brandslund
    Anders Jakobsen
    Journal of Ovarian Research, 5